Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
623.00    5.00 (0.81%)
Bid:
624.00
Ask:
628.00
Spread: 4.00 (0.641%)
Market Cap: £503.65m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Trading Update

5 Mar 2026 07:00

RNS Number : 4763V
Bloomsbury Publishing PLC
05 March 2026
Β 

BLOOMSBURY PUBLISHING PLCΒ 

("Bloomsbury" or "the Company")

Β 

Sarah J. Maas announces the publication dates of her next two novels will be within the next year

Trading Update: FY 2025/26 in line, FY 2026/27 expected to be materially ahead of expectations

Β 

Bestselling author Sarah J. Maas has announced the publication dates of the next two novels in her A Court of Thorns and Roses ('ACOTAR') series which will be published on 27 October 2026 and 12 January 2027.

Nigel Newton, Chief Executive of Bloomsbury, commented, "Fans all over the world are eagerly anticipating reading the next books in the ACOTAR series and we are very excited about this news. Publishing two novels within 11 weeks of each other from a bestselling author is almost unprecedented in publishing history."

Sarah J. Maas was the highest selling author in the United States in 2024 according to Circana sales data and the No.1 bestselling Fantasy author in the UK in 2025. All 16 of Sarah J. Maas' previous novels are published by Bloomsbury.

Bloomsbury expects group profit for the year ended 28 February 2026 to be in-line with market consensus expectations.* This reflects the benefits of Bloomsbury's portfolio of portfolios strategy and includes a strong performance from the Academic division. Looking ahead, group profit for the year ending 28 February 2027 is now expected to be materially ahead of market consensus expectations.*

Further details on trading and outlook will be provided with the Company's Preliminary Results announcement scheduled for 20 May 2026.

Note

* The Board considers market consensus expectation (before this publication) for profit before taxation and highlighted items for the year ending 28 February 2026 to have been Β£44.3m and the year ending 28 February 2027 to have been Β£44.5m.

For further information, please contact:

Bloomsbury Publishing Plc

Β 

Tamsin Garrity, Group Investor Relations Director

tamsin.garrity@bloomsbury.com

Hudson Sandler

Dan de Belder / Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com

Disclaimer

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

The information in this announcement has not been audited or otherwise independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. None of the Company or any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss whatsoever arising from any use of this announcement, or its contents, or otherwise arising in connection with this announcement.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares of the Company.

Certain statements, statistics and projections in this announcement are or may be forward looking. By their nature, forward?looking statements involve a number of risks, uncertainties or assumptions that may or may not occur and actual results or events may differ materially from those expressed or implied by the forward-looking statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Accordingly, forward-looking statements contained in this announcement regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which are based on the knowledge and information available only at the date of this announcement's preparation.

The Company does not undertake any obligation to update or keep current the information contained in this announcement, including any forward?looking statements, or to correct any inaccuracies which may become apparent and any opinions expressed in it are subject to change without notice.

References in this announcement to other reports or materials, such as a website address, have been provided to direct the reader to other sources of information on Bloomsbury Publishing Plc which may be of interest. Neither the content of Bloomsbury's website nor any website accessible by hyperlinks from Bloomsbury's website nor any additional materials contained or accessible thereon, are incorporated in, or form part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFIFVEVTIEIIR
Date   Source Headline
18th Jul 20237:00 amRNSAGM Trading Update
23rd Jun 20232:29 pmRNSAnnual Financial Report
2nd Jun 202311:50 amRNSDirector/PDMR Shareholding
1st Jun 20239:34 amRNSDirector Declaration
31st May 20232:04 pmRNSInvestor Presentation
31st May 20237:00 amRNSAudited Preliminary Results
16th May 20237:00 amRNSNotice of Capital Markets Event
2nd May 20232:43 pmRNSNotice of Results
12th Apr 20233:16 pmRNSHolding(s) in Company
11th Apr 202310:03 amRNSHolding(s) in Company
15th Mar 20237:00 amRNSTrading Update
1st Mar 20237:00 amRNSNotice of Trading Update
17th Feb 20232:09 pmRNSBLOCK LISTING SIX MONTHLY RETURN
11th Jan 20239:08 amRNSHolding(s) in Company
18th Nov 20222:29 pmRNSHolding(s) in Company
14th Nov 20225:16 pmRNSHolding(s) in Company
2nd Nov 20222:56 pmRNSDirector/PDMR Shareholding
1st Nov 20225:16 pmRNSHolding(s) in Company
31st Oct 20227:00 amRNSInvestor Presentation
27th Oct 20221:02 pmEQSBloomsbury Publishing pleased with 'surge in the numbers'
26th Oct 20227:00 amRNSUnaudited Interim Results
14th Oct 202212:41 pmRNSHolding(s) in Company
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Sep 202211:16 amRNSHolding(s) in Company
24th Aug 20225:01 pmRNSDirector/PDMR Shareholding
22nd Aug 20224:16 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSBlock Listing Six Monthly Return
10th Aug 20225:22 pmRNSDirector/PDMR Shareholding
29th Jul 20225:25 pmRNSHolding(s) in Company
20th Jul 20224:32 pmRNSResults of the 2022 Annual General Meeting
20th Jul 20227:00 amRNSAGM Trading Update
4th Jul 20223:52 pmRNSNotice of AGM Clarification
1st Jul 20227:00 amRNSBloomsbury wins Small Cap Award
28th Jun 20224:42 pmRNSAnnual Financial Report
15th Jun 20227:00 amRNSAudited Preliminary Results
25th May 202210:50 amRNSDirector Declaration
24th May 20227:00 amRNSNotice of Results
26th Apr 20224:22 pmRNSHolding(s) in Company
25th Apr 202211:52 amRNSHolding(s) in Company
22nd Apr 20222:12 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSTrading Update
11th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Feb 20222:50 pmRNSBlock Listing Six Monthly Return
26th Jan 20227:00 amRNSTrading Update
19th Jan 20225:45 pmRNSHolding(s) in Company
16th Dec 20217:00 amRNSAcquisition
27th Oct 20217:00 amRNSUnaudited Interim Results
27th Oct 20217:00 amRNSInvestor Presentation
8th Oct 20218:00 amRNSAbdulrazak Gurnah wins Nobel Prize in Literature

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.